Fund shareholders of Novavax Inc
ISIN US6700024010 · United States · LEI 529900J4GJHPEPQ23205
- Fund shareholders
- 165
- Of which ETFs
- 39 126 other funds
- Value held
- ≈ 307.8M $ 307.4M $ · 352.4K €
- Share of capital
- 22.3 % of 164.9M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 12,200 | 99.3K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PACE Small/Medium Co Growth Equity Investments PACE SELECT ADVISORS TRUST | 12,118 | 96K $ | 0.04 % | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 11,875 | 120.4K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 11,630 | 94.7K $ | 0.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 11,417 | 92.9K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 10,831 | 88.2K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 10,654 | 108K $ | 0.04 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 10,391 | 84.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Wellington Small Cap Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 9,871 | 80.3K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 9,302 | 75.7K $ | 0.04 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 9,271 | 73.5K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 9,269 | 94K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 9,242 | 93.7K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 9,157 | 74.5K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 9,091 | 92.2K $ | 0.12 % | 0.01 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 8,300 | 65.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 7,856 | 62.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 7,504 | 76.1K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 7,011 | 71.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 6,489 | 65.8K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 6,001 | 47.6K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF PIMCO Equity Series | 5,963 | 48.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 5,944 | 48.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 5,211 | 41.3K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 4,752 | 48.2K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 4,750 | 38.7K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 4,100 | 33.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 4,084 | 33.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 4,053 | 32.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 4,019 | 32.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 3,954 | 32.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,836 | 31.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 3,533 | 28.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,470 | 35.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 2,886 | 22.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,581 | 21K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 2,472 | 20.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 2,200 | 17.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 2,156 | 17.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| HUSSMAN STRATEGIC ALLOCATION FUND Hussman Investment Trust | 2,000 | 16.3K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,714 | 14K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,689 | 13.4K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,138 | 9.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 968 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 964 | 7.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 874 | 6.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 834 | 6.6K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 816 | 6.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 757 | 6.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 734 | 6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 529 | 5.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 501 | 4.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 378 | 3.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 366 | 3.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 338 | 2.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 273 | 2.2K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 228 | 1.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 208 | 1.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 154 | 1.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 146 | 1.2K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 77 | 780.8 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 63 | 499.3 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 48 | 486.7 $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 39 | 317.5 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| CINVEST,FI CINVEST / A&A INTERNATIONAL INVESTMENT GESALCALA, S.A., S.G.I.I.C. | 352.4K € | 2.48 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ProShares Nanotechnology ETF ProShares Trust | 2.55 % | as of Feb 28, 2026 ↗ |
| CINVEST,FI CINVEST / A&A INTERNATIONAL INVESTMENT GESALCALA, S.A., S.G.I.I.C. | 2.48 % | as of Dec 31, 2025 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.93 % | as of Apr 30, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 1.31 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.06 % | as of Feb 28, 2026 ↗ |
| Golden Eagle Dynamic Hypergrowth ETF ETF Opportunities Trust | 1.06 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.51 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.50 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Value AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 0.46 % | as of Apr 30, 2026 ↗ |
| MFS Blended Research Small Cap Equity Fund MFS SERIES TRUST X | 0.41 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 164 | +11 | 36,840,190 | -0.4 % |
| 2026Q1 | 153 | -5 | 36,984,882 | +10.4 % |
| 2025Q4 | 158 | -2 | 33,504,799 | -0.6 % |
| 2025Q3 | 160 | +4 | 33,697,970 | -0.6 % |
| 2025Q2 | 156 | +5 | 33,903,247 | -1.4 % |
| 2025Q1 | 151 | -5 | 34,376,681 | -2.5 % |
| 2024Q4 | 156 | +13 | 35,262,417 | +27.1 % |
| 2024Q3 | 143 | +9 | 27,742,967 | -30.1 % |
| 2024Q2 | 134 | 0 | 39,711,034 | +3.6 % |
| 2024Q1 | 134 | -9 | 38,325,521 | +37.2 % |
| 2023Q4 | 143 | 27,929,887 |
Institutional managers
250 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SHAH CAPITAL MANAGEMENT | 14,845,097 | 120.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 12,844,319 | 104.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,970,518 | 73M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 7,709,858 | 62.8M $ | as of Mar 31, 2026 |
| Sanofi | 6,880,481 | 56M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 6,637,213 | 54M $ | as of Mar 31, 2026 |
| UBS Group AG | 4,477,701 | 36.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,898,413 | 31.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,852,545 | 31.4M $ | as of Mar 31, 2026 |
| COATUE MANAGEMENT LLC | 3,836,986 | 31.2M $ | as of Mar 31, 2026 |
| Allianz Asset Management GmbH | 1,859,854 | 15.1M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,518,211 | 12.4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,509,326 | 12.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,409,446 | 11.5M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,373,505 | 11.2M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 1,191,079 | 9.7M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,166,197 | 9.5M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,123,746 | 9.1M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 834,842 | 6.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 780,797 | 6.4M $ | as of Mar 31, 2026 |
| Monaco Asset Management SAM | 697,600 | 5.7M $ | as of Mar 31, 2026 |
| Jefferies Financial Group Inc. | 673,120 | 5.5M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 614,799 | 5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 572,034 | 4.7M $ | as of Mar 31, 2026 |
| Edgestream Partners, L.P. | 520,135 | 4.2M $ | as of Mar 31, 2026 |
Declared shareholders of Novavax Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Shah Capital Management and 2 others | 9.03 % | 14,841,000 | as of May 14, 2026 · SCHEDULE 13D |
| Vanguard Capital Management | 5.09 % | 8,305,681 | as of Mar 31, 2026 · SCHEDULE 13G |
| BANK OF AMERICA CORP /DE/ | 4.10 % | 6,655,398 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Novavax Inc
2 funds declare 2 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Fidelity Convertible Securities Fund | 1 | 1.2M $ | as of Feb 28, 2026 |
| Fidelity Strategic Dividend and Income Fund | 1 | 456.4K $ | as of Feb 28, 2026 |
Cite this page
Titelia. "Fund shareholders of Novavax Inc". https://titelia.com/en/stocks/novavax-inc-US6700024010